ABCB1 and cancer: The involvement of MDR1 in the resistance mechanism against PROTACs was confirmed by Kurimchak et al. They observed that high endogenous levels of the MDR1 protein in PROTACs-naïve cancer cells significantly reduced the efficacy of CRBN-recruiting dBet6 PROTAC, compared to the cells with low expression of MDR1.